Walter Longo

1.9k total citations
62 papers, 843 citations indexed

About

Walter Longo is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Walter Longo has authored 62 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 18 papers in Hematology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Walter Longo's work include Lymphoma Diagnosis and Treatment (17 papers), CAR-T cell therapy research (13 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Walter Longo is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), CAR-T cell therapy research (13 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Walter Longo collaborates with scholars based in United States, Germany and Sweden. Walter Longo's co-authors include Brad S. Kahl, Jae Werndli, Jens C. Eickhoff, Thomas McFarland, Jules H. Blank, KyungMann Kim, Eliot C. Williams, H. Ian Robins, Nirav N. Shah and Natalie S. Callander and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Walter Longo

58 papers receiving 821 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Walter Longo 387 254 254 154 121 62 843
Narendranath Epperla 452 1.2× 471 1.9× 115 0.5× 267 1.7× 94 0.8× 147 1.0k
Kris M. Mahadeo 461 1.2× 73 0.3× 329 1.3× 210 1.4× 191 1.6× 113 1.2k
Renata Zaucha 455 1.2× 133 0.5× 193 0.8× 166 1.1× 232 1.9× 54 1.1k
Masahito Tsurusawa 317 0.8× 306 1.2× 390 1.5× 139 0.9× 162 1.3× 90 1.2k
Kathleen Jentsch‐Ullrich 148 0.4× 145 0.6× 313 1.2× 243 1.6× 89 0.7× 46 882
Muna Qayed 315 0.8× 47 0.2× 207 0.8× 192 1.2× 111 0.9× 80 886
Delia Dima 173 0.4× 86 0.3× 240 0.9× 139 0.9× 36 0.3× 70 645
Kelvin Lee 211 0.5× 93 0.4× 210 0.8× 85 0.6× 137 1.1× 39 730
Jacob Garcia 867 2.2× 203 0.8× 60 0.2× 72 0.5× 81 0.7× 47 1.0k
B. Pignon 285 0.7× 201 0.8× 429 1.7× 190 1.2× 41 0.3× 44 832

Countries citing papers authored by Walter Longo

Since Specialization
Citations

This map shows the geographic impact of Walter Longo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Longo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Longo more than expected).

Fields of papers citing papers by Walter Longo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Longo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Longo. The network helps show where Walter Longo may publish in the future.

Co-authorship network of co-authors of Walter Longo

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Longo. A scholar is included among the top collaborators of Walter Longo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Longo. Walter Longo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Nirav N., Bryon D. Johnson, Anikó Szabó, et al.. (2025). Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma. Journal of Clinical Oncology. 43(20). 2285–2295. 2 indexed citations
3.
Furqan, Fateeha, Binod Dhakal, Timothy S. Fenske, et al.. (2024). Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS intervention. Blood Advances. 8(16). 4320–4329. 5 indexed citations
4.
Akhtar, Othman Salim, Kwang Woo Ahn, Anita D’Souza, et al.. (2024). Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 30(12). 1191.e1–1191.e8. 1 indexed citations
5.
Chhabra, Saurabh, James H. Jerkins, Kathleen Monahan, et al.. (2024). Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 59(3). 373–379. 4 indexed citations
6.
Furqan, Fateeha, Walter Longo, Sumana Devata, et al.. (2024). Split-Dose R-CHOP for Older Patients with Treatment Naïve DLBCL. Blood. 144(Supplement 1). 2374–2374.
7.
Shah, Nirav N., Anikó Szabó, Dina Schneider, et al.. (2024). Phase 1 Study of Trispecific Anti-CD20, Anti-CD19, Anti-CD22 (CAR20.19.22) T Cells for Relapsed, Refractory B-Cell Malignancies. Blood. 144(Supplement 1). 3448–3448.
8.
Abid, Muhammad Bilal, Anikó Szabó, Walter Longo, et al.. (2023). Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohort Analysis. Transplantation and Cellular Therapy. 30(3). 285–297. 9 indexed citations
9.
Shah, Nirav N., Anikó Szabó, Saurabh Rajguru, et al.. (2023). Phase II trial of split-dose R-CHOP for older patients with diffuse large B-cell lymphoma (DLBCL).. Journal of Clinical Oncology. 41(16_suppl). 7554–7554. 1 indexed citations
10.
Shah, Nirav N., Fenlu Zhu, Dina Schneider, et al.. (2019). Fresh Versus Cryopreserved/Thawed Bispecific Anti-CD19/CD20 CAR-T Cells for Relapsed, Refractory Non-Hodgkin Lymphoma. Blood. 134(Supplement_1). 4465–4465. 7 indexed citations
11.
Abedin, Sameem, Saurabh Chhabra, Marcelo C. Pasquini, et al.. (2019). Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(8). 1689–1694. 68 indexed citations
12.
Chang, Elizabeth, Christopher G. Peterson, Sangbum Choi, et al.. (2011). VcR‐CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study. British Journal of Haematology. 155(2). 190–197. 43 indexed citations
13.
Chang, Julie, Jae Werndli, Wayne A. Bottner, et al.. (2010). Rituximab and CHOP Chemotherapy Plus GM-CSF for Previously Untreated Diffuse Large B-Cell Lymphoma in the Elderly: A Wisconsin Oncology Network Study. Clinical Lymphoma Myeloma & Leukemia. 10(5). 379–384. 13 indexed citations
14.
Perlman, Scott B., et al.. (2008). F-18 FDG PET Imaging of GVHD-Associated Polymyositis. Clinical Nuclear Medicine. 33(10). 688–689. 14 indexed citations
15.
Chang, Julie, Brad S. Kahl, Walter Longo, et al.. (2008). Augmented and standard Berlin–Frankfurt–Münster chemotherapy for treatment of adult acute lymphoblastic leukemia. Leukemia & lymphoma. 49(12). 2298–2307. 38 indexed citations
16.
Kujawski, Lisa, Walter Longo, Eliot C. Williams, et al.. (2007). A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas. Cancer Investigation. 25(2). 87–93. 13 indexed citations
17.
Kahl, Brad S., Walter Longo, Jens C. Eickhoff, et al.. (2006). Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network. Annals of Oncology. 17(9). 1418–1423. 82 indexed citations
18.
Bahadursingh, Anil, Parsia A. Vagefi, & Walter Longo. (2004). Fulminant Clostridium Difficile Colitis In A Patient With Spinal Cord Injury: Case Report. Journal of Spinal Cord Medicine. 27(3). 266–268. 1 indexed citations
19.
Robins, H. Ian, Justin Cohen, Carol L. Schmitt, et al.. (1993). Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients.. Journal of Clinical Oncology. 11(9). 1787–1794. 46 indexed citations
20.
Robins, H. Ian, Walter Longo, Richard A. Steeves, et al.. (1990). Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable b-cell neoplasms: a report of two pilot clinical trials and laboratory investigations. International Journal of Radiation Oncology*Biology*Physics. 18(4). 909–920. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026